Here, we compared the kinetics of the CD4+ T-cell response to FBL-3 tumor antigen in drLN with the CD8+ T-cell response and found a more rapid development of the CD4+ T-cell response after FBL-3 injection. This evidence concerns the gene CD8A and neoplasm.